Peter J P Croucher

4PUBLICATIONS
44CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 20, 2025
PLK1 Inhibition Induces Synthetic Lethality in Fanconi Anemia Pathway-Deficient Acute Myeloid Leukemia.

Aditya S Sheth, Ka-Kui Chan, Sheng Liu

|Oct 30, 2024
Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.

Daniel H Ahn, Maya Ridinger, Timothy L Cannon

|Jan 17, 2024
Onvansertib in Combination with FOLFIRI and Bevacizumab in Second-Line Treatment of KRAS-Mutant Metastatic Colorectal Cancer: A Phase Ib Clinical Study.

Daniel H Ahn, Afsaneh Barzi, Maya Ridinger

|Nov 22, 2022
Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling.

Jesse C Patterson, Andreas Varkaris, Peter J P Croucher

Pageof 1

Frequent Collaborators

4 joint publications

Maya Ridinger

3 joint publications

Heinz-Josef Lenz

2 joint publications

Ramanand A Subramanian

2 joint publications

Errin Samuëlsz